期刊
CURRENT OPINION IN CELL BIOLOGY
卷 45, 期 -, 页码 102-109出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2017.05.007
关键词
-
类别
资金
- Susan G. Komen Breast Cancer Foundation [IIR12224057]
- CIHR [MOP-7214]
- Canadian Cancer Society [2010-700377]
- Vanier Canada Graduate Scholarship [267839]
- Rosalind Goodman Commemorative Scholarship (GCRC)
The evidence for the importance of aberrant translation in cancer cells is overwhelming. Reflecting the wealth of data, there are excellent reviews delineating how ribosomes and initiation factors are linked to cancer [1-3], and the therapeutic strategies being devised to target them [4]. Changes in translational efficiency can engender a malignant phenotype without the need for chromatin reorganization, transcription, splicing and mRNA export [5,6]. Thus, cancer-related modulations of the translational machinery are ideally suited to allow cancer cells to respond to the various stresses encountered along the path of tumorigenesis and organismwide dissemination [7(center dot),8,9,10(center dot)]. Emerging findings supporting this notion are the focus of this review.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据